LGALS3 and Myocardial fibrosis: ,603 In experimental HF models, MR blockade decreases the expression of galectin-3 (Gal-3) and soluble ST2 (sST2) without interfering with IL-33-mediated cardioprotection, which are associated with the reduction of myocardial fibrosis and inflammation.604